“We were given the opportunity to engage with Genentech in 1977, two years before its IPO [initial public offering], and we ...

Investors who adopt systems thinking when approaching the space economy can enhance their ability to understand and influence ...

On March 6, Jared Holz, Mizuho health care equity strategist, appeared on CNBC’s ‘Power Lunch’ to discuss investing in biotech and the oversaturation in the sector. He said that looking at ...

TANZANIA is at a critical turning point- staring down the double-barreled microscope of industrial growth and scientific ...

Revolution Medicines is a clinical-stage pharma company with a market cap of ~6 billion. Click here to find out why RVMD ...

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other ...

Novonesis, a world-leading biosolutions company, recognizes the importance of the National Security Commission on Emerging Biotechnology (NSCEB) report as a pivotal milestone in charting a bold path ...

These 15 funds lost billions in shareholder value over the past decade, even during a bull market. Discover which leveraged ...

A revolution in oncology could help the 18 million cancer survivors in the U.S. and bolster Guardant Health, Natera and Exact Sciences.

We recently published a list of the 10 Best Mid Cap Biotech Stocks to Buy. In this article, we are going to take a look at where Revolution Medicines, Inc. (NASDAQ:RVMD) stands against the other best ...

Ministerial discussions were held on April 17 within the framework of the 4th Partnership for Green Growth and the Global ...

Modern biotechnology began in 1973 when scientists used recombination to genetically engineer an antibiotic-resistant strain of Escherichia coli bacteria. This began a revolution in molecule ...